Oral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer. J Clin Oncol 2002, 20(4):1026?035. 37. Smollich M, Gotte M, Fischgrabe J, Radke I, Kiesel L, Wulfing P: Differential effects of aromatase inhibitors and antiestrogens on estrogen receptor expression in breast cancer cells. Anticancer Res 2009, 29(6):2167?171. 38. Torrisi R, Bagnard